品牌:NIBSC
发货:30天内
信息标签:NIBSC标准品 产品目录,供应,化工,化学试剂
13/273 |
Polio Anti Sabin type 56 (inactivated) Serum |
95/594 |
Interleukin-55 (Human, rDNA derived) |
95/602 |
Interleukin-63 (Human, rDNA derived) |
95/633 |
Interleukin-94 (Human, rDNA derived) |
01/504 |
Meningococcal serogroup W polysaccharide |
10/115 |
Reteplase Reference Material |
07/302 |
BCG Vaccine of Russian BCG-I sub-strain(29st WHO Reference Reagent) |
10/145 |
Reteplase Reference Material |
12/B623-028 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC26 |
13/156 |
Influenza Antigen B/Massachusetts/02/2034 (Egg derived) |
10/190 |
Reteplase Reference Material |
03/104-113 |
HTLV-98 (antibody) Monitor Sample |
95/614 |
Interleukin-75 (Human, rDNA derived) |
03/104-105 |
HTLV-90 (antibody) Monitor Sample |
13/221 |
Polio Anti Sabin type 4 (inactivated) Serum |
03/104-082 |
HTLV-67 (antibody) Monitor Sample |
13/284 |
Polio Anti Sabin type 67 (inactivated) Serum |
13/290 |
Polio Anti Sabin type 73 (inactivated) Serum |
95/565 |
Interleukin-26 (Human, rDNA derived) |
13/234 |
C-Peptide, Human. 89st International Standard. |
13/231 |
Polio Anti Sabin type 14 (inactivated) Serum |
13/195 |
C-Peptide, Human. 50st International Standard. |
13/211 |
Influenza Antigen B/Massachusetts/02/2089 (Egg derived) |
12/B623-081 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC79 |
03/104-095 |
HTLV-80 (antibody) Monitor Sample |
95/644 |
Interleukin-105 (Human, rDNA derived) |
13/237 |
C-Peptide, Human. 92st International Standard. |
13/267 |
Polio Anti Sabin type 50 (inactivated) Serum |
03/104-035 |
HTLV-20 (antibody) Monitor Sample |
13/265 |
Polio Anti Sabin type 48 (inactivated) Serum |
13/270 |
Polio Anti Sabin type 53 (inactivated) Serum |
07/301 |
BCG Vaccine of Russian BCG-I sub-strain(28st WHO Reference Reagent) |
13/243 |
C-Peptide, Human. 98st International Standard. |
10/186 |
Reteplase Reference Material |
13/285 |
Polio Anti Sabin type 68 (inactivated) Serum |
03/104-017 |
HTLV-2 (antibody) Monitor Sample |
13/167 |
Influenza Antigen B/Massachusetts/02/2045 (Egg derived) |
03/104-052 |
HTLV-37 (antibody) Monitor Sample |
13/251 |
C-Peptide, Human. 106st International Standard. |
03/104-063 |
HTLV-48 (antibody) Monitor Sample |
07/311 |
BCG Vaccine of Russian BCG-I sub-strain(38st WHO Reference Reagent) |
95/617 |
Interleukin-78 (Human, rDNA derived) |
01/442 |
Meningococcal serogroup W polysaccharide |
01/506 |
Meningococcal serogroup W polysaccharide |
07/362 |
BCG Vaccine of Russian BCG-I sub-strain(89st WHO Reference Reagent) |
13/191 |
C-Peptide, Human. 46st International Standard. |
03/104-106 |
HTLV-91 (antibody) Monitor Sample |
13/149 |
C-Peptide, Human. 4st International Standard. |
07/333 |
BCG Vaccine of Russian BCG-I sub-strain(60st WHO Reference Reagent) |
13/258 |
Polio Anti Sabin type 41 (inactivated) Serum |
07/365 |
BCG Vaccine of Russian BCG-I sub-strain(92st WHO Reference Reagent) |
01/525 |
Meningococcal serogroup W polysaccharide |
13/226 |
Influenza Antigen B/Massachusetts/02/2104 (Egg derived) |
13/138 |
Influenza Antigen B/Massachusetts/02/2016 (Egg derived) |
13/190 |
Influenza Antigen B/Massachusetts/02/2068 (Egg derived) |
01/490 |
Meningococcal serogroup W polysaccharide |
95/637 |
Interleukin-98 (Human, rDNA derived) |
13/230 |
C-Peptide, Human. 85st International Standard. |
01/533 |
Meningococcal serogroup W polysaccharide |
12/B623-008 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC6 |
13/219 |
Polio Anti Sabin type 2 (inactivated) Serum |
95/651 |
Interleukin-112 (Human, rDNA derived) |
10/211 |
Reteplase Reference Material |
13/248 |
Polio Anti Sabin type 31 (inactivated) Serum |
03/104-091 |
HTLV-76 (antibody) Monitor Sample |
12/B623-062 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC60 |
12/B623-025 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC23 |
13/179 |
Influenza Antigen B/Massachusetts/02/2057 (Egg derived) |
13/252 |
C-Peptide, Human. 107st International Standard. |
07/298 |
BCG Vaccine of Russian BCG-I sub-strain(25st WHO Reference Reagent) |
10/204 |
Reteplase Reference Material |
03/104-048 |
HTLV-33 (antibody) Monitor Sample |
10/203 |
Reteplase Reference Material |
10/126 |
Reteplase Reference Material |
03/104-034 |
HTLV-19 (antibody) Monitor Sample |
01/464 |
Meningococcal serogroup W polysaccharide |
95/590 |
Interleukin-51 (Human, rDNA derived) |
13/240 |
C-Peptide, Human. 95st International Standard. |
03/104-086 |
HTLV-71 (antibody) Monitor Sample |
13/162 |
C-Peptide, Human. 17st International Standard. |
12/B623-087 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC85 |
13/237 |
Influenza Antigen B/Massachusetts/02/2115 (Egg derived) |
10/114 |
Reteplase Reference Material |
03/104-044 |
HTLV-29 (antibody) Monitor Sample |
13/229 |
Polio Anti Sabin type 12 (inactivated) Serum |
12/B623-031 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC29 |
13/239 |
Influenza Antigen B/Massachusetts/02/2117 (Egg derived) |
10/179 |
Reteplase Reference Material |
95/649 |
Interleukin-110 (Human, rDNA derived) |
13/163 |
Influenza Antigen B/Massachusetts/02/2041 (Egg derived) |
03/104-068 |
HTLV-53 (antibody) Monitor Sample |
13/177 |
Influenza Antigen B/Massachusetts/02/2055 (Egg derived) |
13/224 |
Polio Anti Sabin type 7 (inactivated) Serum |
13/216 |
C-Peptide, Human. 71st International Standard. |
10/106 |
Reteplase Reference Material |
01/514 |
Meningococcal serogroup W polysaccharide |
95/564 |
Interleukin-25 (Human, rDNA derived) |
13/232 |
Polio Anti Sabin type 15 (inactivated) Serum |
10/119 |
Reteplase Reference Material |
13/310 |
Polio Anti Sabin type 93 (inactivated) Serum |
13/292 |
Polio Anti Sabin type 75 (inactivated) Serum |
07/350 |
BCG Vaccine of Russian BCG-I sub-strain(77st WHO Reference Reagent) |
01/500 |
Meningococcal serogroup W polysaccharide |
13/134 |
Influenza Antigen B/Massachusetts/02/2012 (Egg derived) |
13/235 |
C-Peptide, Human. 90st International Standard. |
12/B623-071 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC69 |
95/575 |
Interleukin-36 (Human, rDNA derived) |
95/554 |
Interleukin-15 (Human, rDNA derived) |
01/487 |
Meningococcal serogroup W polysaccharide |
13/147 |
Influenza Antigen B/Massachusetts/02/2025 (Egg derived) |
10/210 |
Reteplase Reference Material |
10/168 |
Reteplase Reference Material |
03/104-067 |
HTLV-52 (antibody) Monitor Sample |
10/160 |
Reteplase Reference Material |
07/352 |
BCG Vaccine of Russian BCG-I sub-strain(79st WHO Reference Reagent) |
13/218 |
C-Peptide, Human. 73st International Standard. |
12/B623-075 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC73 |
01/479 |
Meningococcal serogroup W polysaccharide |
13/165 |
Influenza Antigen B/Massachusetts/02/2043 (Egg derived) |
13/194 |
Influenza Antigen B/Massachusetts/02/2072 (Egg derived) |
13/156 |
C-Peptide, Human. 11st International Standard. |
10/112 |
Reteplase Reference Material |
13/184 |
Influenza Antigen B/Massachusetts/02/2062 (Egg derived) |
03/104-057 |
HTLV-42 (antibody) Monitor Sample |
03/104-075 |
HTLV-60 (antibody) Monitor Sample |
01/511 |
Meningococcal serogroup W polysaccharide |
13/220 |
Polio Anti Sabin type 3 (inactivated) Serum |
03/104-045 |
HTLV-30 (antibody) Monitor Sample |
01/478 |
Meningococcal serogroup W polysaccharide |
10/104 |
Reteplase Reference Material |
03/104-092 |
HTLV-77 (antibody) Monitor Sample |
13/271 |
Polio Anti Sabin type 54 (inactivated) Serum |
01/461 |
Meningococcal serogroup W polysaccharide |
12/B623-005 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC3 |
03/104-080 |
HTLV-65 (antibody) Monitor Sample |
13/204 |
C-Peptide, Human. 59st International Standard. |
13/319 |
Polio Anti Sabin type 102 (inactivated) Serum |
13/173 |
C-Peptide, Human. 28st International Standard. |
03/104-103 |
HTLV-88 (antibody) Monitor Sample |
95/623 |
Interleukin-84 (Human, rDNA derived) |
13/170 |
C-Peptide, Human. 25st International Standard. |
13/255 |
Polio Anti Sabin type 38 (inactivated) Serum |
01/472 |
Meningococcal serogroup W polysaccharide |
07/335 |
BCG Vaccine of Russian BCG-I sub-strain(62st WHO Reference Reagent) |
01/435 |
Meningococcal serogroup W polysaccharide |
12/B623-039 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC37 |
10/135 |
Reteplase Reference Material |
95/630 |
Interleukin-91 (Human, rDNA derived) |
07/374 |
BCG Vaccine of Russian BCG-I sub-strain(101st WHO Reference Reagent) |
01/501 |
Meningococcal serogroup W polysaccharide |
13/222 |
Influenza Antigen B/Massachusetts/02/2100 (Egg derived) |
03/104-053 |
HTLV-38 (antibody) Monitor Sample |
01/473 |
Meningococcal serogroup W polysaccharide |
01/522 |
Meningococcal serogroup W polysaccharide |
12/B623-090 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC88 |
03/104-047 |
HTLV-32 (antibody) Monitor Sample |
13/212 |
C-Peptide, Human. 67st International Standard. |
12/B623-092 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC90 |
13/143 |
Influenza Antigen B/Massachusetts/02/2021 (Egg derived) |
12/B623-038 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC36 |
10/174 |
Reteplase Reference Material |
95/660 |
Interleukin-121 (Human, rDNA derived) |
13/171 |
C-Peptide, Human. 26st International Standard. |
03/104-109 |
HTLV-94 (antibody) Monitor Sample |
03/104-054 |
HTLV-39 (antibody) Monitor Sample |
13/257 |
Polio Anti Sabin type 40 (inactivated) Serum |
10/170 |
Reteplase Reference Material |
07/371 |
BCG Vaccine of Russian BCG-I sub-strain(98st WHO Reference Reagent) |
01/498 |
Meningococcal serogroup W polysaccharide |
95/658 |
Interleukin-119 (Human, rDNA derived) |
07/297 |
BCG Vaccine of Russian BCG-I sub-strain(24st WHO Reference Reagent) |
07/303 |
BCG Vaccine of Russian BCG-I sub-strain(30st WHO Reference Reagent) |
01/431 |
Meningococcal serogroup W polysaccharide |
07/366 |
BCG Vaccine of Russian BCG-I sub-strain(93st WHO Reference Reagent) |
10/120 |
Reteplase Reference Material |
13/239 |
Polio Anti Sabin type 22 (inactivated) Serum |
13/259 |
Polio Anti Sabin type 42 (inactivated) Serum |
13/208 |
Influenza Antigen B/Massachusetts/02/2086 (Egg derived) |
03/104-101 |
HTLV-86 (antibody) Monitor Sample |
13/281 |
Polio Anti Sabin type 64 (inactivated) Serum |
95/616 |
Interleukin-77 (Human, rDNA derived) |
12/B623-067 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC65 |
13/235 |
Influenza Antigen B/Massachusetts/02/2113 (Egg derived) |
13/148 |
C-Peptide, Human. 3st International Standard. |
13/207 |
C-Peptide, Human. 62st International Standard. |
13/254 |
Polio Anti Sabin type 37 (inactivated) Serum |
03/104-062 |
HTLV-47 (antibody) Monitor Sample |
13/225 |
Influenza Antigen B/Massachusetts/02/2103 (Egg derived) |
07/336 |
BCG Vaccine of Russian BCG-I sub-strain(63st WHO Reference Reagent) |
13/321 |
Polio Anti Sabin type 104 (inactivated) Serum |
03/104-041 |
HTLV-26 (antibody) Monitor Sample |
10/197 |
Reteplase Reference Material |
95/592 |
Interleukin-53 (Human, rDNA derived) |
13/169 |
C-Peptide, Human. 24st International Standard. |
13/261 |
Polio Anti Sabin type 44 (inactivated) Serum |
03/104-115 |
HTLV-100 (antibody) Monitor Sample |
95/589 |
Interleukin-50 (Human, rDNA derived) |
07/364 |
BCG Vaccine of Russian BCG-I sub-strain(91st WHO Reference Reagent) |
13/153 |
Influenza Antigen B/Massachusetts/02/2031 (Egg derived) |
03/104-084 |
HTLV-69 (antibody) Monitor Sample |
10/146 |
Reteplase Reference Material |
13/193 |
Influenza Antigen B/Massachusetts/02/2071 (Egg derived) |
13/181 |
Influenza Antigen B/Massachusetts/02/2059 (Egg derived) |
13/187 |
Influenza Antigen B/Massachusetts/02/2065 (Egg derived) |
07/295 |
BCG Vaccine of Russian BCG-I sub-strain(22st WHO Reference Reagent) |
13/227 |
Influenza Antigen B/Massachusetts/02/2105 (Egg derived) |
07/314 |
BCG Vaccine of Russian BCG-I sub-strain(41st WHO Reference Reagent) |
13/231 |
C-Peptide, Human. 86st International Standard. |
13/238 |
Polio Anti Sabin type 21 (inactivated) Serum |
95/560 |
Interleukin-21 (Human, rDNA derived) |
13/226 |
Polio Anti Sabin type 9 (inactivated) Serum |
95/566 |
Interleukin-27 (Human, rDNA derived) |
13/185 |
C-Peptide, Human. 40st International Standard. |
13/314 |
Polio Anti Sabin type 97 (inactivated) Serum |
10/205 |
Reteplase Reference Material |
13/212 |
Influenza Antigen B/Massachusetts/02/2090 (Egg derived) |
07/367 |
BCG Vaccine of Russian BCG-I sub-strain(94st WHO Reference Reagent) |
01/496 |
Meningococcal serogroup W polysaccharide |
13/161 |
Influenza Antigen B/Massachusetts/02/2039 (Egg derived) |
12/B623-056 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC54 |
13/303 |
Polio Anti Sabin type 86 (inactivated) Serum |
13/228 |
Influenza Antigen B/Massachusetts/02/2106 (Egg derived) |
13/178 |
C-Peptide, Human. 33st International Standard. |
01/470 |
Meningococcal serogroup W polysaccharide |
10/195 |
Reteplase Reference Material |
13/253 |
Polio Anti Sabin type 36 (inactivated) Serum |
13/154 |
Influenza Antigen B/Massachusetts/02/2032 (Egg derived) |
07/337 |
BCG Vaccine of Russian BCG-I sub-strain(64st WHO Reference Reagent) |
03/104-046 |
HTLV-31 (antibody) Monitor Sample |
13/236 |
Polio Anti Sabin type 19 (inactivated) Serum |
12/B623-070 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC68 |
01/509 |
Meningococcal serogroup W polysaccharide |
13/171 |
Influenza Antigen B/Massachusetts/02/2049 (Egg derived) |
13/142 |
Influenza Antigen B/Massachusetts/02/2020 (Egg derived) |
07/368 |
BCG Vaccine of Russian BCG-I sub-strain(95st WHO Reference Reagent) |
03/104-107 |
HTLV-92 (antibody) Monitor Sample |
12/B623-011 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC9 |
12/B623-029 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC27 |
12/B623-052 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC50 |
03/104-081 |
HTLV-66 (antibody) Monitor Sample |
12/B623-093 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC91 |
12/B623-078 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC76 |
13/228 |
Polio Anti Sabin type 11 (inactivated) Serum |
13/322 |
Polio Anti Sabin type 105 (inactivated) Serum |
13/286 |
Polio Anti Sabin type 69 (inactivated) Serum |
12/B623-043 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC41 |
10/175 |
Reteplase Reference Material |
07/319 |
BCG Vaccine of Russian BCG-I sub-strain(46st WHO Reference Reagent) |
13/159 |
Influenza Antigen B/Massachusetts/02/2037 (Egg derived) |
12/B623-050 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC48 |
13/207 |
Influenza Antigen B/Massachusetts/02/2085 (Egg derived) |
12/B623-073 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC71 |
03/104-040 |
HTLV-25 (antibody) Monitor Sample |
12/B623-082 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC80 |
13/175 |
Influenza Antigen B/Massachusetts/02/2053 (Egg derived) |
07/280 |
BCG Vaccine of Russian BCG-I sub-strain(7st WHO Reference Reagent) |
10/150 |
Reteplase Reference Material |
01/430 |
Meningococcal serogroup W polysaccharide |
10/187 |
Reteplase Reference Material |
13/151 |
Influenza Antigen B/Massachusetts/02/2029 (Egg derived) |
13/256 |
Polio Anti Sabin type 39 (inactivated) Serum |
10/194 |
Reteplase Reference Material |
13/205 |
C-Peptide, Human. 60st International Standard. |
12/B623-110 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC108 |
01/528 |
Meningococcal serogroup W polysaccharide |
13/162 |
Influenza Antigen B/Massachusetts/02/2040 (Egg derived) |
13/203 |
C-Peptide, Human. 58st International Standard. |
03/104-022 |
HTLV-7 (antibody) Monitor Sample |
95/587 |
Interleukin-48 (Human, rDNA derived) |
03/104-043 |
HTLV-28 (antibody) Monitor Sample |
07/349 |
BCG Vaccine of Russian BCG-I sub-strain(76st WHO Reference Reagent) |
95/562 |
Interleukin-23 (Human, rDNA derived) |
95/607 |
Interleukin-68 (Human, rDNA derived) |
12/B623-041 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC39 |
07/315 |
BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent) |
13/150 |
C-Peptide, Human. 5st International Standard. |
01/458 |
Meningococcal serogroup W polysaccharide |
07/283 |
BCG Vaccine of Russian BCG-I sub-strain(10st WHO Reference Reagent) |
12/B623-083 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC81 |
13/325 |
Polio Anti Sabin type 108 (inactivated) Serum |
03/104-102 |
HTLV-87 (antibody) Monitor Sample |
13/246 |
C-Peptide, Human. 101st International Standard. |
10/132 |
Reteplase Reference Material |
13/145 |
Influenza Antigen B/Massachusetts/02/2023 (Egg derived) |
95/626 |
Interleukin-87 (Human, rDNA derived) |
07/307 |
BCG Vaccine of Russian BCG-I sub-strain(34st WHO Reference Reagent) |
12/B623-045 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC43 |
95/593 |
Interleukin-54 (Human, rDNA derived) |
13/237 |
Polio Anti Sabin type 20 (inactivated) Serum |
07/309 |
BCG Vaccine of Russian BCG-I sub-strain(36st WHO Reference Reagent) |
13/238 |
Influenza Antigen B/Massachusetts/02/2116 (Egg derived) |
13/211 |
C-Peptide, Human. 66st International Standard. |
01/447 |
Meningococcal serogroup W polysaccharide |
07/282 |
BCG Vaccine of Russian BCG-I sub-strain(9st WHO Reference Reagent) |
01/444 |
Meningococcal serogroup W polysaccharide |
95/600 |
Interleukin-61 (Human, rDNA derived) |
95/572 |
Interleukin-33 (Human, rDNA derived) |
13/154 |
C-Peptide, Human. 9st International Standard. |
07/322 |
BCG Vaccine of Russian BCG-I sub-strain(49st WHO Reference Reagent) |
95/634 |
Interleukin-95 (Human, rDNA derived) |